抗體名：甲型流感病毒血凝素抗體

抗體英文名：H1N1 Hemagglutinin 2 Antibody

應用范圍：WB: 1:100-500 E: 1:500-1000 IP: 1:20-100 IHC: 1:100-500 IF: 1:100-500

產品用途：科研實驗，用于免疫組化實驗，WB實驗，相應的標記抗體有HRP標記抗體，FITC標記，BIO等。產品用途：科研實驗，用于免疫組化實驗，WB實驗，相應的標記抗體有HRP標記抗體，FITC標記，BIO等。

免疫原：Peptide derived from Influenza A Virus Hemagglutinin C-terminus.

標記物：無標記（PLlabs可供應生物素、酶、熒光素標記的抗體）

適應物種：Influenza A virus H1N1

靶點：H1N1 Hemagglutinin 2

濃度：1mg/ml

宿主：Rabbit

克隆性：多克隆

保存條件：保存于-20℃

形態：液態

亞型：Rabbit Polyclonal IgG

規格：0.1ml

Background：

Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues.